BC21713 Taspoglutide vs sitagliptin and placebo in Type 2 diabetes

• Research type

  Research Study

• Full title

  BC21713 - A multicentre, randomised, double-blind, double-dummy, placebo- and active-controlled study to assess the efficacy, safety and tolerability of taspoglutide (R05073031) compared to sitagliptin and placebo in patients with type 2 diabetes mellitus inadequately controlled with metformin.

• IRAS ID

  3739

• Contact name

  Iain McColl

• Contact email

  iaincmccoll@hotmail.com

• Sponsor organisation

  F Hoffmann-La Roche

• Eudract number

  2008-001854-42

• ISRCTN Number

  NA

• REC name

  Scotland A REC

• REC reference

  08/MRE00/82

• Date of REC Opinion

  12 Nov 2008

• REC opinion

  Further Information Favourable Opinion